NO166131C - Analogifremgangsmaate for fremstilling av s(-)-pyridobenzoksazinforbindelser. - Google Patents

Analogifremgangsmaate for fremstilling av s(-)-pyridobenzoksazinforbindelser.

Info

Publication number
NO166131C
NO166131C NO862426A NO862426A NO166131C NO 166131 C NO166131 C NO 166131C NO 862426 A NO862426 A NO 862426A NO 862426 A NO862426 A NO 862426A NO 166131 C NO166131 C NO 166131C
Authority
NO
Norway
Prior art keywords
compounds
pyridobenzoksazine
preparation
preparing
optically active
Prior art date
Application number
NO862426A
Other languages
English (en)
Norwegian (no)
Other versions
NO862426D0 (no
NO862426L (no
NO166131B (no
Inventor
Isao Hayakawa
Shohgo Atarashi
Shuichi Yokohama
Masazumi Imamura
Katsuichi Sakano
Nobuyuki Higashihashi
Masayuki Ohshima
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27281433&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO166131(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP60226499A external-priority patent/JPH0720946B2/ja
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of NO862426D0 publication Critical patent/NO862426D0/no
Publication of NO862426L publication Critical patent/NO862426L/no
Priority to NO883791A priority Critical patent/NO169896C/no
Publication of NO166131B publication Critical patent/NO166131B/no
Publication of NO166131C publication Critical patent/NO166131C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO862426A 1985-06-20 1986-06-18 Analogifremgangsmaate for fremstilling av s(-)-pyridobenzoksazinforbindelser. NO166131C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO883791A NO169896C (no) 1985-06-20 1988-08-25 3-s-3-alkylbenzoksazinderivater

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP13471285 1985-06-20
JP60226499A JPH0720946B2 (ja) 1985-10-11 1985-10-11 光学活性３−メチルベンゾオキサジン誘導体およびその製法
JP1649686 1986-01-28

Publications (4)

Publication Number Publication Date
NO862426D0 NO862426D0 (no) 1986-06-18
NO862426L NO862426L (no) 1986-12-22
NO166131B NO166131B (no) 1991-02-25
NO166131C true NO166131C (no) 1991-06-05

Family

ID=27281433

Family Applications (1)

Application Number Title Priority Date Filing Date
NO862426A NO166131C (no) 1985-06-20 1986-06-18 Analogifremgangsmaate for fremstilling av s(-)-pyridobenzoksazinforbindelser.

Country Status (16)

Country Link
US (3) US5053407A (de)
EP (1) EP0206283B1 (de)
KR (2) KR920010048B1 (de)
AT (1) ATE85057T1 (de)
BG (1) BG60527B2 (de)
CA (1) CA1304080C (de)
DE (2) DE3687599T2 (de)
DK (1) DK170473B1 (de)
ES (1) ES8801251A1 (de)
FI (1) FI90241C (de)
GR (1) GR861625B (de)
HK (1) HK91793A (de)
IE (1) IE59463B1 (de)
NL (1) NL980016I2 (de)
NO (1) NO166131C (de)
YU (3) YU44918B (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE110061T1 (de) * 1986-12-25 1994-09-15 Daiichi Seiyaku Co Optisch aktive 2,3-dihydrobenzoxazinderivate und verfahren zu deren herstellung.
FI95567C (fi) * 1987-12-25 1996-02-26 Daiichi Seiyaku Co Propoksibentseenijohdannaisia ja menetelmä niiden valmistamiseksi
MY104139A (en) * 1988-08-09 1994-02-28 Daiichi Seiyaku Co Antimicrobial agent for animals
US5175160A (en) * 1988-08-09 1992-12-29 Daiichi Pharmaceutical Co., Ltd. Antimicrobial agent for animals
AU4376589A (en) * 1988-11-07 1990-05-10 Gist-Brocades N.V. Optically active benzoxazines and benzothiazines
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
FR2655545B1 (fr) * 1989-12-11 1994-06-10 Rhone Poulenc Sante Nouvelle application therapeutique des derives des fluoroquinolones.
TW208013B (de) * 1990-03-01 1993-06-21 Daiichi Co Ltd
NO179912C (no) * 1990-11-28 1997-01-08 Daiichi Seiyaku Co Analogifremgangsmåte for fremstilling av et terapeutisk virksomt optisk aktivt pyridobenzoksazinderivat
EP0619311A1 (de) * 1992-10-07 1994-10-12 Derivados Del Etilo, S.A. Verfahren zur herstellung von benzoxazine verwendbar zur herstellung von ofloxacin, levofloxacin und derivate
ES2055656B1 (es) * 1992-10-07 1995-11-16 Etilo Derivados Procedimiento para la obtencion de benzoxazinas utiles para sintesis de ofloxacina, levofloxacina y derivados.
US5532239A (en) * 1993-08-02 1996-07-02 Assistance Publique - Hopitaux De Paris Therapeutic application of fluoroquinolone derivatives
ZA946853B (en) * 1993-09-10 1995-04-24 Daiichi Seiyaku Co Crystals of antimicrobial compound.
US5686095A (en) * 1995-10-23 1997-11-11 Price, Jr.; Francis W. Method of treating canker sores
NZ332762A (en) 1996-07-24 2000-09-29 Warner Lambert Co Isobutylgaba and its derivatives for the treatment of pain
US6022551A (en) * 1998-01-20 2000-02-08 Ethicon, Inc. Antimicrobial composition
US5972358A (en) * 1998-01-20 1999-10-26 Ethicon, Inc. Low tack lotion, gels and creams
US6248343B1 (en) 1998-01-20 2001-06-19 Ethicon, Inc. Therapeutic antimicrobial compositions
US5997893A (en) * 1998-01-20 1999-12-07 Ethicon, Inc. Alcohol based anti-microbial compositions with cosmetic appearance
KR100309871B1 (ko) 1999-02-24 2001-10-29 윤종용 (-)피리도벤즈옥사진 카르복실산 유도체의 제조방법
AU757777B2 (en) 1998-12-04 2003-03-06 Influx, Inc. Inhibitors of multidrug transporters
KR100617952B1 (ko) * 1999-03-04 2006-08-30 보령제약 주식회사 광학활성 피리도 벤즈옥사진 유도체의 제조방법
EP2218722B9 (de) * 1999-09-08 2013-06-19 Daiichi Sankyo Company, Limited Verfahren zur Herstellung von Benzoxazinderivaten und Zwischenprodukten dafür
KR20010103346A (ko) * 2000-05-09 2001-11-23 이후근 패각 입자와 접착제 그리고 물감을 혼합하여 그림 밑칠용재료를 제조하는 방법
JP2004518677A (ja) 2000-12-21 2004-06-24 ファルマシア・アンド・アップジョン・カンパニー 抗菌性キノロン誘導体および細菌感染を治療するためのその使用
CN100465286C (zh) 2001-03-07 2009-03-04 第一制药株式会社 光学活性的丙氧基苯胺衍生物的制备方法
CN1201028C (zh) 2001-04-27 2005-05-11 浦项产业科学研究院 具有优越热加工性能的高锰二联不锈钢及其制造方法
US7425628B2 (en) 2001-10-03 2008-09-16 Teva Pharmaceutical Industries Ltd. Methods for the purification of levofloxacin
JP2005504818A (ja) 2001-10-03 2005-02-17 テバ ファーマシューティカル インダストリーズ リミティド レボフロキサシンおよびその形態の調製
KR100440192B1 (ko) * 2001-11-22 2004-07-12 이수화학 주식회사 광학 활성 퀴놀론카르복실산 유도체의 제조방법
JP2005527484A (ja) * 2001-11-29 2005-09-15 テバ ファーマシューティカル インダストリーズ リミティド レボフロキサシンの精製製法
BR0215413A (pt) * 2001-12-24 2004-12-14 Teva Pharma Formula dosada com um comprimido central de ingrediente ativo encapado em uma capa anular prensada de material em pó ou granulado e processo e conjunto de ferramentas para a sua produção
US20040052843A1 (en) * 2001-12-24 2004-03-18 Lerner E. Itzhak Controlled release dosage forms
EP2266590A3 (de) 2002-02-22 2011-04-20 Shire LLC Wirkstoff-Abgabesystem und Verfahren zum Schutz und zur Verabreichung von Wirkstoffen
AU2003262704A1 (en) * 2002-08-14 2004-08-30 Teva Pharmaceutical Industries Ltd. Synthesis of gatifloxacin
US20040152701A1 (en) * 2002-12-02 2004-08-05 Dr. Reddy's Laboratories Limited Novel anhydrous crystalline form of Levofloxacin and process for preparation there of
FR2859471B1 (fr) 2003-09-09 2006-02-03 Solvay Procede pour la fabrication d'un compose enantiopur
US20080194640A1 (en) 2005-02-07 2008-08-14 Mitsuharu Nakamura Optically Active Tetrahydronaphthalene Derivative
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US7838532B2 (en) * 2005-05-18 2010-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US9155792B2 (en) * 2006-02-13 2015-10-13 Trustees Of Boston University RecA inhibitors with antibiotic activity, compositions and methods of use
US20070197548A1 (en) 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
US7973022B2 (en) 2006-02-17 2011-07-05 Idexx Laboratories, Inc. Fluoroquinolone carboxylic acid salt compositions
WO2008019292A2 (en) * 2006-08-04 2008-02-14 Trustees Of Boston University Compositions and methods for potentiating antibiotic activity
EP1939206A1 (de) * 2006-12-22 2008-07-02 Farmaprojects, S.A. Herstellungsverfahren für eine antibakterielle Quinolonverbindung
US20100029938A1 (en) * 2006-12-22 2010-02-04 Farmaprojects, S. A. Process for the preparation of an antibacterial quinolone compound
US7964723B2 (en) 2008-08-02 2011-06-21 Apeloa-Kangyu And practical process for exclusively producing (S)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido-[1,2,3,de][1,4]benzoxazine-6-carboxylic acid hemihydrate
CN102325532B (zh) 2008-10-07 2015-06-17 Mpex医药有限公司 用于减轻肺部炎症的左氧氟沙星吸入剂
NZ631469A (en) 2008-10-07 2016-06-24 Raptor Pharmaceuticals Inc Aerosol fluoroquinolone formulations for improved pharmacokinetics
SG176056A1 (en) 2009-05-15 2011-12-29 Redx Pharma Ltd Redox drug derivatives
LT2473170T (lt) 2009-09-04 2019-10-10 Horizon Orphan Llc Aerozolizuoto levofloksacino panaudojimas cistinės fibrozės gydymui
CN101659669B (zh) * 2009-09-04 2011-07-20 诚达药业股份有限公司 左旋氧氟沙星的制备方法
CN102775424A (zh) * 2012-07-09 2012-11-14 浙江司太立制药股份有限公司 一种左氧氟沙星杂质的制备方法
KR102237887B1 (ko) 2013-03-15 2021-04-07 멜린타 서브시디어리 코프. 항생제를 사용하여 과체중 및 비만 환자에서 감염을 치료하는 방법
JP6400121B2 (ja) 2014-05-09 2018-10-03 テクニメデ ソシエダーデ テクニコ−メディシナル エス．アー． 医療用のピルリンドールエナンチオマーの薬学的に許容可能な塩
CN105037388A (zh) * 2015-08-28 2015-11-11 安徽环球药业股份有限公司 一种安妥沙星的制备方法
CN105367585B (zh) * 2015-12-02 2017-11-17 山东齐都药业有限公司 左氧氟沙星杂质的制备方法
US20230233572A1 (en) 2020-06-11 2023-07-27 Sentiss Pharma Private Limited Ophthalmic compositions comprising a combination of fluoroquinolone antibacterial agent and an anti-inflammatory agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
JPS5852290A (ja) * 1981-09-21 1983-03-28 Dai Ichi Seiyaku Co Ltd ピリドベンゾオキサジンカルボン酸誘導体
DE3543513A1 (de) * 1985-12-10 1987-06-11 Bayer Ag Enantiomerenreine 1,8-verbrueckte 4-chinolon-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel und ihre verwendung zur herstellung von arzneimitteln

Also Published As

Publication number Publication date
NO862426D0 (no) 1986-06-18
NO862426L (no) 1986-12-22
EP0206283B1 (de) 1993-01-27
IE861631L (en) 1986-12-20
YU45524B (en) 1992-05-28
NL980016I2 (nl) 1998-08-03
DE3687599T2 (de) 1993-05-19
BG60527B2 (bg) 1995-07-28
KR870000340A (ko) 1987-02-17
US5142046A (en) 1992-08-25
YU186788A (en) 1989-04-30
KR920010048B1 (ko) 1992-11-13
FI862643A0 (fi) 1986-06-19
YU44918B (en) 1991-04-30
KR940003757B1 (ko) 1994-04-30
FI90241C (fi) 1994-01-10
ES556292A0 (es) 1988-01-01
DK285086A (da) 1986-12-21
KR920009279A (ko) 1992-05-28
YU107386A (en) 1988-02-29
DK285086D0 (da) 1986-06-18
IE59463B1 (en) 1994-02-23
DE19875012I2 (de) 2006-06-29
EP0206283A2 (de) 1986-12-30
ATE85057T1 (de) 1993-02-15
US4985557A (en) 1991-01-15
GR861625B (en) 1986-10-21
YU45512B (en) 1992-05-28
FI90241B (fi) 1993-09-30
US5053407A (en) 1991-10-01
NO166131B (no) 1991-02-25
DE3687599D1 (de) 1993-03-11
YU209889A (en) 1990-04-30
HK91793A (en) 1993-09-10
NL980016I1 (nl) 1998-07-01
DK170473B1 (da) 1995-09-11
CA1304080C (en) 1992-06-23
ES8801251A1 (es) 1988-01-01
FI862643A (fi) 1986-12-21
EP0206283A3 (en) 1988-08-10

Similar Documents

Publication Publication Date Title
NO166131C (no) Analogifremgangsmaate for fremstilling av s(-)-pyridobenzoksazinforbindelser.
NO911600D0 (no) Fremgangsmaate for fremstilling av n-(3-fluor-2-fosfonyl-metoksypropyl)-derivater av heterocykliske purin- og pyrimidinbaser.
ES2017498B3 (es) Derivado de 2-fenilbenzoxepina.
NO168243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
DK508885A (da) Esterderivat af antibiotekum l 17046 og fremgangsmaade til fremstilling deraf
ES548330A0 (es) Un metodo de preparacion de un compuesto de tiadiazina
NO174963C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 8-fluorantracyklinglucosider
EP0486687A4 (en) Quinolonecarboxylic acid derivatives
AU553765B2 (en) Biologically active heterocyclic hydroximidates and thiolhydroximidates and carbamate ester derivatives thereof
AU2013888A (en) Uricosuric composition
ES2039270T3 (es) Derivados de gamma-l-glutamil-4-nitroanilida y procedimiento para determinar actividad de gamma-gtp utilizandolos.
GR3002699T3 (en) Process for stabilising procaterol
HUT38920A (en) Process for producing anticonvulsive tetrahydro-1,2,4-oxadiazine-5-thion derivatives
SU1573830A1 (ru) Фосфорилированные оксиэтиловые эфиры 2,4-дихлорфеноксиуксусной кислоты, обладающие гербицидной активностью
SU1455633A1 (ru) О,о-диизопропил-о-[1, 1-диметил-2-пропилтио-2-(о-о-диизопропилфосфорил)- имино]-этилфосфат, обладающий бактерицидной активностью

Legal Events

Date Code Title Description
MK1K Patent expired